Does balloon catheter sinuplasty have a role in the surgical management of pediatric sinus disease?

Sedaghat, Ahmad R.; Cunningham, Michael J.

doi:10.1002/lary.21929

Cited by 17 publications

(25 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…One criticism of balloon sinuplasty involves the cost. It is reported to cost approximately $1,500 per patient . In a cross‐sectional study looking at pediatric patients undergoing ESS versus balloon dilation, it was noted that there were significantly higher charges, without significant changes in operating room time, for the balloon group compared to the ESS group .…”

Section: Discussionmentioning

confidence: 99%

Adenoidectomy With Balloon Catheter Sinuplasty: A Randomized Trial for Pediatric Rhinosinusitis

Gerber

Kennedy

2018

The Laryngoscope

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Adenoidectomy With Balloon Catheter Sinuplasty: A Randomized Trial for Pediatric Rhinosinusitis

Gerber

Kennedy

2018

The Laryngoscope

View full text Add to dashboard Cite

show abstract

“…The additional expense of new technology must also be considered with the utilization of balloon technology for treatment of CRS. 1171 As delivery of topical medications has become an increasingly important treatment modality in the management of CRS, the impact of sinus surgery to enhance such delivery must be considered. Postoperative distribution of topical medications to the paranasal sinuses may be limited by utilization of more conservative ESS techniques, such as MIST or balloon dilation.…”

Section: S147mentioning

confidence: 99%

International Consensus Statement on Allergy and Rhinology: Rhinosinusitis

Orlandi

Kingdom

Hwang

et al. 2016

Int Forum Allergy Rhinol

559

888

View full text Add to dashboard Cite

Background:The body of knowledge regarding rhinosinusitis (RS) continues to expand, with rapid growth in number of publications, yet substantial variability in the quality of those presentations. In an effort to both consolidate and critically appraise this information, rhinologic experts from around the world have produced the International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR:RS). Methods:Evidence-based reviews with recommendations (EBRRs) were developed for scores of topics, using previously reported methodology. Where existing evidence was insufficient for an EBRR, an evidence-based review (EBR) was produced. The sections were then synthesized and the entire manuscript was then reviewed by all authors for consensus. Results:The resulting ICAR:RS document addresses multiple topics in RS, including acute RS (ARS), chronic RS (CRS) with and without nasal polyps (CRSwNP and CRSsNP), recurrent acute RS (RARS), acute exacerbation of CRS (AE-CRS), and pediatric RS. Conclusion:As a critical review of the RS literature, ICAR:RS provides a thorough review of pathophysiology and evidence-based recommendations for medical and surgical treatment. It also demonstrates the significant gaps in our understanding of the pathophysiology and optimal management of RS. Too o en the foundation upon which these recommendations are based is comprised of lowerlevel evidence. It is our hope that this summary of the evidence in RS will point out where additional research efforts may be directed. C 2016 ARS-AAOA, LLC. Key Words:rhinosinusitis; chronic rhinosinusitis; acute rhinosinusitis; recurrent acute rhinosinusitis; evidence-based medicine; systematic review; endoscopic sinus surgery List of Abbreviations Used

show abstract

“…More recently, BCS has been evaluated for safety and efficacy of treatment of chronic rhinosinusitis in the pediatric population. BCS appears to be safe and effective, according to recent cohort studies, [47–50] and in contrast to ESS, it does not involve tissue removal and spares mucosa. This noninvasive technique may be particularly beneficial in the pediatric age group and thus in a group of CF patients.…”

Section: Managementmentioning

confidence: 99%

Sinonasal Manifestations in Cystic Fibrosis

Oomen

April

2012

International Journal of Otolaryngology

View full text Add to dashboard Cite

Cystic fibrosis is a genetic disease, characterized by accumulation of thickened mucous secretions in exocrine glands. Although the major clinical manifestations of the disease are pancreatic and pulmonary disease, the majority of cystic fibrosis patients will develop sinonasal manifestations as well. This paper outlines the etiology, evaluation, and management of the nasal and sinus manifestations in patients with cystic fibrosis.

show abstract

Does balloon catheter sinuplasty have a role in the surgical management of pediatric sinus disease?

Cited by 17 publications

References 5 publications

Adenoidectomy With Balloon Catheter Sinuplasty: A Randomized Trial for Pediatric Rhinosinusitis

Adenoidectomy With Balloon Catheter Sinuplasty: A Randomized Trial for Pediatric Rhinosinusitis

International Consensus Statement on Allergy and Rhinology: Rhinosinusitis

Sinonasal Manifestations in Cystic Fibrosis

Contact Info

Product

Resources

About